Melita Sun Jung - Jan 30, 2025 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role: Chief Business Officer
Signature: /s/ David Strauss, as Attorney-in-Fact for Melita Sun Jung
Stock symbol: TERN
Transactions as of: Jan 30, 2025
Transactions value $: $11,498
Form type: 4
Date filed: 2/3/2025, 07:28 PM
Previous filing: May 2, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TERN	Common Stock	Purchase	$11.5K	+2.25K		$5.11	2.25K	Nov 30, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TERN	Stock Option (Right to Buy)	Award	$0	+325K		$0.00	325K	Jan 30, 2025	Common Stock	325K	$4.64	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 2,250 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2024.
F2	25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.